Alliance Global Partners Forecasts Curaleaf FY2024 Earnings

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Alliance Global Partners upped their FY2024 earnings per share (EPS) estimates for Curaleaf in a research report issued on Thursday, November 7th. Alliance Global Partners analyst A. Grey now expects that the company will earn ($0.26) per share for the year, up from their previous forecast of ($0.27). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Alliance Global Partners also issued estimates for Curaleaf’s Q4 2024 earnings at ($0.08) EPS, Q1 2025 earnings at ($0.07) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.25) EPS.

Several other brokerages also recently commented on CURLF. Needham & Company LLC reaffirmed a “buy” rating and set a $6.25 target price on shares of Curaleaf in a report on Thursday, August 8th. Cormark downgraded Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.

Curaleaf Trading Down 22.1 %

Shares of OTCMKTS CURLF opened at $1.66 on Monday. Curaleaf has a 12 month low of $1.64 and a 12 month high of $6.40. The company has a market cap of $1.08 billion, a price-to-earnings ratio of -5.72 and a beta of 0.86. The company has a quick ratio of 0.50, a current ratio of 1.09 and a debt-to-equity ratio of 0.83. The business has a fifty day simple moving average of $2.95 and a 200-day simple moving average of $3.77.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.